492 related articles for article (PubMed ID: 15377486)
21. Rituximab in the treatment of autoimmune haematological disorders.
Garvey B
Br J Haematol; 2008 Apr; 141(2):149-69. PubMed ID: 18318765
[TBL] [Abstract][Full Text] [Related]
22. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
[TBL] [Abstract][Full Text] [Related]
23. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
24. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
25. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
[TBL] [Abstract][Full Text] [Related]
26. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
Tamimoto Y; Horiuchi T; Tsukamoto H; Otsuka J; Mitoma H; Kimoto Y; Nakashima H; Muta K; Abe Y; Kiyohara C; Ueda A; Nagasawa K; Yoshizawa S; Shimoda T; Harada M
Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955
[TBL] [Abstract][Full Text] [Related]
27. Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.
Svahn J; Fioredda F; Calvillo M; Molinari AC; Micalizzi C; Banov L; Schmidt M; Caprino D; Marinelli D; Gallisai D; Dufour C
Br J Haematol; 2009 Apr; 145(1):96-100. PubMed ID: 19208098
[TBL] [Abstract][Full Text] [Related]
28. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab.
Gottardo NG; Baker DL; Willis FR
Pediatr Hematol Oncol; 2003; 20(7):557-61. PubMed ID: 12959862
[TBL] [Abstract][Full Text] [Related]
29. Successful management of severe chronic autoimmune hemolytic anemia with low dose cyclosporine and prednisone in an infant.
Yarali N; Fişgin T; Kara A; Duru F
Turk J Pediatr; 2003; 45(4):335-7. PubMed ID: 14768800
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune hemolytic anemia in pediatric liver or combined liver and small bowel transplant patients: a case series and review of the literature.
Li M; Goldfinger D; Yuan S
Transfusion; 2012 Jan; 52(1):48-54. PubMed ID: 21790626
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
[TBL] [Abstract][Full Text] [Related]
32. [Mixed-type autoimmune hemolytic anemia after splenectomy for idiopathic thrombocytopenic purpura].
Toyota S; Nakamura N; Dan K
Rinsho Ketsueki; 2001 Jan; 42(1):51-3. PubMed ID: 11235135
[TBL] [Abstract][Full Text] [Related]
33. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Smith KG; Jones RB; Burns SM; Jayne DR
Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
[TBL] [Abstract][Full Text] [Related]
34. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
[TBL] [Abstract][Full Text] [Related]
35. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
36. Acquired immune cytopenias post-cardiac transplantation respond to rituximab.
Tubman VN; Smoot L; Heeney MM
Pediatr Blood Cancer; 2007 Mar; 48(3):339-44. PubMed ID: 16435382
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.
Retana AK; Kaplan MM; Erban JK
Am J Gastroenterol; 2007 Jan; 102(1):197-200. PubMed ID: 17037996
[TBL] [Abstract][Full Text] [Related]
38. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
39. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
